| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |